5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE Solution

Country: Canada

Language: French

Source: Health Canada

Active ingredient:

Dextrose; L-leucine; L-phénylalanine; Lysine (Chlorhydrate de L-lysine); Méhionine; L-isoleucine; L-valine; Histidine; L-thréonine; Tryptophane; L-ALANINE; L-arginine; L-proline; Sérine; Glycine; L-tyrosine

Available from:

BAXTER CORPORATION CLINTEC NUTRITION DIVISION

ATC code:

B05BA10

INN (International Name):

COMBINATIONS

Dosage:

20G; 365MG; 280MG; 290MG; 200MG; 300MG; 290MG; 240MG; 210MG; 90MG; 1.04G; 575MG; 340MG; 250MG; 515MG; 20MG

Pharmaceutical form:

Solution

Composition:

Dextrose 20G; L-leucine 365MG; L-phénylalanine 280MG; Lysine (Chlorhydrate de L-lysine) 290MG; Méhionine 200MG; L-isoleucine 300MG; L-valine 290MG; Histidine 240MG; L-thréonine 210MG; Tryptophane 90MG; L-ALANINE 1.04G; L-arginine 575MG; L-proline 340MG; Sérine 250MG; Glycine 515MG; L-tyrosine 20MG

Administration route:

Intraveineuse

Units in package:

2000ML

Prescription type:

Spécialité médicale

Therapeutic area:

CALORIC AGENTS

Product summary:

Numéro de groupe d'ingrédients actifs (GIA) :1650849010; AHFS:

Authorization status:

ANNULÉ APRÈS COMMERCIALISATION

Authorization date:

2015-08-05